Table 1.
Patients (n = 266) | |
---|---|
Gender, n (%) | |
Male | 203 (76) |
Female | 63 (24) |
Age (years) | |
Median ± SD | 69.0 ± 10.9 |
Range | 20–91 |
Histology, n (%) | |
Epithelioid | 201 (78) |
Biphasic | 30 (12) |
Sarcomatoid | 21 (8) |
Desmoplastic | 5 (2) |
Lymphohistiocytoid | 2 (1) |
Asbestos exposure, n (%) | |
Exposed | 186 (81) |
Nonexposed | 45 (19) |
Tobacco consumption, n (%) | |
Smoker | 142 (55) |
Nonsmoker | 116 (45) |
Stage IMIG, n (%) | |
I | 5 (2) |
II | 32 (14) |
III | 99 (45) |
IV | 86 (39) |
Surgical treatment, n (%) | |
EP | 70 (26) |
PD | 36 (14) |
AR | 8 (3) |
None | 152 (57) |
Chemotherapy treatment, n (%) | |
Yes | 189 (77) |
No | 56 (23) |
Survival status, n (%) | |
Deceased patients | 204 (82) |
Alive patients | 46 (18) |
Survival (months) | |
Median | 19.8 |
Range | 0.1–178.3 |